pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
cocaine hydrochloride
Numbrino (cocaine hydrochloride)
Local Anesthetic Effect
Cody Laboratories Inc
0 catalysts
Preclinical
colesevelam
COLESEVELAM (colesevelam [INN])
Diarrhea
Viscera Labs Inc
0 catalysts
Marketed
colesevelam hydrochloride
Colesevelam Hydrochloride (colesevelam hydrochloride)
Heterozygous Familial Hypercholesterolemia (heFH)
Nivagen Pharmaceuticals Inc
0 catalysts
← prev
page 167 of 231
next →
131
Pain89
Neurology1
Marketed
colestipol hydrochloride
Colestipol Hydrochloride (colestipol hydrochloride)
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)
Carnegie Pharmaceuticals LLC
0 catalysts
Marketed
colistimethate sodium
Colistimethate Sodium (colistimethate sodium)
Lower Respiratory Tract Infections
Xellia Pharmaceuticals USA LLC
0 catalysts
Marketed
collagenase clostridium histolyticum
Xiaflex (collagenase clostridium histolyticum)
Peyronies Disease
Auxilium Pharmaceuticals LLC
0 catalysts
Phase 2
comekibart
comekibart [INN]
Atopic Dermatitis (Atopic Eczema)
Shanghai Mabgeek Biotechnology Co Ltd
0 catalysts
Phase 1
comtifator
Alzheimer's Disease
Bristol-Myers Squibb Co
0 catalysts
Marketed
concizumab
Alhemo (concizumab)
Hemophilia A (Factor VIII Deficiency)
Novo Nordisk Inc
0 catalysts
Marketed
conestat alfa
Ruconest (conestat alfa [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Pharming Healthcare, Inc.
0 catalysts
Marketed
conivaptan hydrochloride
Vaprisol (conivaptan hydrochloride)
Hyponatremia
$CPIXCUMBERLAND PHARMACEUTICALS INC
0 catalysts
Marketed
conjugated estrogens
Conjugated Estrogens (conjugated estrogens)
Hypoestrogenism
Ingenus Pharmaceuticals LLC
0 catalysts
Phase 3
contezolid
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0 catalysts
Phase 3
contezolid acefosamil
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0 catalysts
Marketed
copanlisib hydrochloride
Aliqopa (copanlisib hydrochloride)
Follicular Lymphoma
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Phase 3
coramitug
Amyloid Cardiomyopathy
Novo Nordisk AS
0 catalysts
Phase 2
corticorelin
corticorelin [INN]
Peritumoral Brain Edema
Curatis AG
0 catalysts
Marketed
corticotropin
Acthar (corticotropin [INN])
Membranous Glomerulonephritis
Cerium Pharmaceuticals Inc
0 catalysts
Phase 3
crenolanib besylate
Refractory Acute Myeloid Leukemia
Arog Pharmaceuticals Inc
0 catalysts
Phase 3
cretostimogene grenadenorepvec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$CGONCG Oncology, Inc.
0 catalysts
Marketed
crinecerfont
Crenessity (crinecerfont)
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)
$NBIXNEUROCRINE BIOSCIENCES INC
0 catalysts
Marketed
crisaborole
Eucrisa (crisaborole)
Atopic Dermatitis (Atopic Eczema)
$PFEPFIZER INC
0 catalysts
Phase 1
crisdesalazine
crisdesalazine [INN]
Amyotrophic Lateral Sclerosis
GNT Pharma Co Ltd
0 catalysts
Marketed
crizanlizumab
Adakveo (crizanlizumab-tmca)
Sickle Cell Disease
$NVSNOVARTIS AG
0 catalysts
Marketed
crizotinib
Xalkori (crizotinib)
Anaplastic Large Cell Lymphoma (ALCL)
EML4-ALKNPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)
$PFEPFIZER INC
0 catalysts
Marketed
crofelemer DR
Mytesi (crofelemer)
Chemotherapy-Induced Diarrhea (CID)
Anoctamin-1Cystic fibrosis transmembrane conductance regulator
Napo Pharmaceuticals Inc
0 catalysts
Marketed
crotamiton
Crotan (crotamiton [INN])
Pruritus
Marnel Pharmaceuticals LLC
0 catalysts
Phase 3
crovalimab
Piasky (crovalimab-akkz)
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic…
Complement C5
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 1
curcumin
Sickle Cell Disease
Vascarta Inc
0 catalysts
Phase 2
cusatuzumab
cusatuzumab [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
OncoVerity Inc
0 catalysts